Insider Transactions Reported by 18 Insiders of ACADIA PHARMACEUTICALS INC

Symbol
ACAD on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

ACADIA PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BAKER BROS. ADVISORS LP Director, 10%+ Owner $688,336,586 29 May 2025
STEPHEN DAVIS CEO, Director $4,050,942 16 Aug 2024
Srdjan R. Stankovic President $1,834,571 19 Nov 2022
Catherine Owen Chief Executive Officer, Director $1,714,331 24 Mar 2025
Douglas J. Williamson Executive VP, Research & Dev $1,517,624 10 Feb 2023
AUSTIN D. KIM EVP,General Counsel, Secretary $1,405,154 06 Jan 2024
Mark C. Schneyer Evp, Chief Financial Officer $1,341,804 -$1,090,563 -45% 17 Nov 2025
Brendan Teehan Evp, Coo, Head Of Commercial $1,210,623 17 Nov 2024
DANIEL B. SOLAND Director $927,091 29 May 2025
ELIZABETH A. GAROFALO Director $818,321 -$131,234 -14% 02 Sep 2025
EDMUND HARRIGAN Director $770,131 29 May 2025
Thomas Garner EVP, Chief Commercial Officer $762,703 09 Dec 2024
James Kihara Principal Accounting Officer $627,917 -$249,514 -28% 17 Nov 2025
Jennifer J. Rhodes Evp, Chief Legal Officer, Sec $566,625 24 Mar 2025
H.Z. Thompson EVP, Head of Research & Dev $489,676 24 Mar 2025
Laura Brege Director $487,785 -$314,634 -39% 04 Jun 2025
Adora Ndu Director $432,529 29 May 2025
James M. Daly Director $249,397 -$670,983 -73% 10 Nov 2025

Recent Insider Transactions by Companies or Individuals for ACADIA PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.